| Male |  | Female |  |
---|
Normal (n=165) | EKOA (n=17) | p value | Normal (n=184) | EKOA (n=38) | p value |
---|
Age, years
| 50.6±13.9 | 55.7±14.1 | 0.118 | 49.8±13.1 | 53.7±10.8 | 0.039 |
BMI, kg/m
2
| 23.5±2.8 | 24.6±2.3 | 0.092 | 21.7±2.8 | 23.4±4.6 | 0.027 |
KOOS
|
 Symptom
| 96.2±4.7 | 73.9±16.2 | <0.001 | 95.5±5.1 | 78.5±14.2 | <0.001 |
 Pain
| 97.9±4.3 | 75.8±11.8 | <0.001 | 97.8±4.0 | 75.4±14.2 | <0.001 |
 Function
| 99.5±1.3 | 87.9±17.4 | <0.001 | 99.3±1.8 | 88.1±12.4 | <0.001 |
 QOL
| 94.5±9.1 | 55.9±17.4 | <0.001 | 90.7±13.1 | 57.9±15.7 | <0.001 |
KLG 0, n (%)
| 130 (78) | 14 (82) | 0.725 | 135 (73) | 25 (66) | 0.343 |
Effusion- area (mm
2
)
| 39.9±34.2 | 54.6±39.5 | 0.048 | 31.2±30.8 | 50.9±48.1 | 0.002 |
- The values represent the demographic data of all participants, including participants with EKOA (EKOA group) and those without EKOA (non-OA group). Data are presented as mean±standard deviation for the age, BMI, KOOS, and effusion area. The KLG data are based on the number of participants (percentage of the whole population). The Wilcoxon rank-sum test was used to compare the mean values of the age, BMI, KOOS, and effusion area. The chi-squared test was used to compare the proportions of KLG between participants with and without OA.
- BMI Body mass index, EKOA Early knee osteoarthritis, KOOS Knee injury and Osteoarthritis Outcome Score, KLG Kellgren–Lawrence grade, OA Osteoarthritis, QOL Quality of life